Kits Eyecare Achieves Record Growth in Q3 2025

The latest update is out from Kits Eyecare ( (TSE:KITS) ).

Kits Eyecare Ltd. reported a record third quarter in 2025, with a 25.1% increase in revenue year-over-year, reaching $52.4 million. The company also saw a significant rise in net income to $1.9 million and an improvement in adjusted EBITDA by 79% to $2.9 million. This growth is attributed to strategic pricing, an improved product mix, and targeted promotions. With over 1 million active customers and a 36.5% increase in new customers, Kits Eyecare is positioned for sustained momentum and profitability, reflecting disciplined execution in its operations.

The most recent analyst rating on (TSE:KITS) stock is a Hold with a C$15.50 price target. To see the full list of analyst forecasts on Kits Eyecare stock, see the TSE:KITS Stock Forecast page.

Spark’s Take on TSE:KITS Stock

According to Spark, TipRanks’ AI Analyst, TSE:KITS is a Neutral.

Kits Eyecare’s stock score is primarily influenced by its strong financial performance, characterized by robust revenue growth and improved profitability metrics. However, the technical analysis indicates bearish momentum, and the high P/E ratio suggests overvaluation, which negatively impacts the overall score. The absence of earnings call data and corporate events means these factors do not influence the score.

To see Spark’s full report on TSE:KITS stock, click here.

More about Kits Eyecare

Kits Eyecare Ltd. is a leading vertically integrated eyecare provider, focusing on delivering eyecare products such as glasses and contact lenses. The company is known for its customer-centric approach and has a strong market presence with a growing customer base.

Average Trading Volume: 49,187

Technical Sentiment Signal: Hold

Current Market Cap: C$423.6M

See more data about KITS stock on TipRanks’ Stock Analysis page.